Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Gadodiamide is a gadolinium-based contrast agent (GBCA).1,2,3 It induces apoptosis and autophagy in HaCaT keratinocytes and SVG p12 glial cells at 13 mM.1,2 Gadodiamide (2.5 mmol/kg) induces nephrogenic systemic fibrosis-like skin lesions in rats.3 Formulations containing gadodiamide have been used as contrast agents for diagnostic MRI.
WARNING This product is not for human or veterinary use.
1. Gadodiamide induced autophagy and apoptosis in human keratinocytes. In Vivo 36(2), 603-609 (2022).
2. In vitro toxicological assessment of gadodiamide in normal brain SVG P12 cells. In Vivo 35(5), 2621-2630 (2021).
3. A preclinical study to investigate the development of nephrogenic systemic fibrosis: A possible role for gadolinium-